Serena Williams recently made headlines for her promotion of GLP-1 medications. The tennis super star is one of a growing list of celebrities turning to GLP-1s, drugs originally developed to treat patients with Type II diabetes and obesity, to help with weight loss.

Off-label use of these medications is rapidly expanding, disrupting a fitness industry built on helping people lose weight. In May, Weight Watchers filed for bankruptcy. Questions also loom over any long-term disruptions to the human body.

Mike and Yael talk with Dr. Sandhya Chhabra (MBA’17) about the benefits, cautions, and unknowns surrounding the drug that is making headlines and changing lives. Dr. Chhabra led an endocrinology practice for 20 years and is currently a Senior Medical Advisor for Springbok Analytics.

AI requires data, lots of it. Tech companies are rapidly building new data centers to house it, which will require massive amounts of electricity. How do we power them and stay on track with our emission reduction goals?

An unlikely candidate is emerging – nuclear energy. But it’s not the reactor of the 60s that is being built. Small modular nuclear reactors are dispatchable, site-flexible, and safe but can they overcome the regulatory, financial, and public perception hurdles to more broadly scale?

Mike and Yael speak with Stephen Leff (MBA '20), a Project Manager at BWX Technologies and expert in nuclear energy sources about the promise and challenges of this clean tech solution.

If you ask Marvel Comics fans about quantum physics, they might reference time travel, multiverse, quantum realm, and Dr. Strange. Ideas of science fiction. Yet, for decades we have used quantum physics to power MRI machines, solar panels, and lasers. More recently, big tech companies have entered a race to quantum supremacy, where quantum computers surpass silicon-based super computers in speed and complex problem solving. But what is it?

You won’t want to miss this Quantum 101! Mike and Yael have a fascinating discussion about quantum computing with Joab Rosenberg, Founder and General Partner of QBeat Ventures, a venture capital fund that specializes in early-stage investments in quantum technologies.